Literature DB >> 11007969

Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system.

S Rathke-Hartlieb1, P Budde, S Ewert, U Schlomann, M S Staege, H Jockusch, J W Bartsch, J Frey.   

Abstract

Reactive astrocytes occurring in response to neurodegeneration are thought to play an important role in neuronal regeneration by upregulating the expression of extracellular matrix (ECM) components as well as the ECM degrading metalloproteinases (MMPs). We examined the mRNA levels and cellular distribution of membrane type matrix metalloproteinase 1 (MT1-MMP) and tissue inhibitors 1-4 of MMPs (TIMPs) in brain stem and spinal cord of wobbler (WR) mutant mice affected by progressive neurodegeneration and astrogliosis. MT1-MMP, TIMP-1 and TIMP-3 mRNA levels were elevated, whereas TIMP-2 and TIMP-4 expression was not affected. MT1-MMP was expressed in reactive astrocytes of WR. In primary astrocyte cultures, MT1-MMP mRNA was upregulated by exogeneous tumor necrosis factor alpha. Increased plasma membrane and secreted MMP activities were found in primary WR astrocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007969     DOI: 10.1016/s0014-5793(00)02011-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Metalloproteinase alterations in the bone marrow of ALS patients.

Authors:  Patrizia Bossolasco; Lidia Cova; Cinzia Calzarossa; Federica Servida; Niccolò Emanuele Mencacci; Francesco Onida; Elio Polli; Giorgio Lambertenghi Deliliers; Vincenzo Silani
Journal:  J Mol Med (Berl)       Date:  2010-01-21       Impact factor: 4.599

Review 2.  Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

Authors:  H L Fillmore; T E VanMeter; W C Broaddus
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration.

Authors:  U Schlomann; S Rathke-Hartlieb; S Yamamoto; H Jockusch; J W Bartsch
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 4.  Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective.

Authors:  Preantha Poonan; Clement Agoni; Mahmoud A A Ibrahim; Mahmoud E S Soliman
Journal:  Protein J       Date:  2021-09-29       Impact factor: 2.371

Review 5.  The wobbler mouse: a neurodegeneration jigsaw puzzle.

Authors:  Séverine Boillée; Marc Peschanski; Marie-Pierre Junier
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

6.  Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia.

Authors:  Radhika Suryadevara; Spring Holter; Kathleen Borgmann; Raisa Persidsky; Christine Labenz-Zink; Yuri Persidsky; Howard E Gendelman; Li Wu; Anuja Ghorpade
Journal:  Glia       Date:  2003-10       Impact factor: 7.452

7.  ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice.

Authors:  Edward T Mahoney; Richard L Benton; Melissa A Maddie; Scott R Whittemore; Theo Hagg
Journal:  J Comp Neurol       Date:  2009-01-10       Impact factor: 3.215

Review 8.  The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment.

Authors:  Amanda L Placone; Alfredo Quiñones-Hinojosa; Peter C Searson
Journal:  Tumour Biol       Date:  2015-10-22

9.  Extracellular environment contribution to astrogliosis-lessons learned from a tissue engineered 3D model of the glial scar.

Authors:  Daniela N Rocha; José P Ferraz-Nogueira; Cristina C Barrias; João B Relvas; Ana P Pêgo
Journal:  Front Cell Neurosci       Date:  2015-09-29       Impact factor: 5.505

10.  The octadecaneuropeptide ODN protects astrocytes against hydrogen peroxide-induced apoptosis via a PKA/MAPK-dependent mechanism.

Authors:  Yosra Hamdi; Hadhemi Kaddour; David Vaudry; Seyma Bahdoudi; Salma Douiri; Jérôme Leprince; Helene Castel; Hubert Vaudry; Marie-Christine Tonon; Mohamed Amri; Olfa Masmoudi-Kouki
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.